Cancer is becoming one of the most common diseases that is affecting people from all walks of life. Everybody is affected, and its effects are devastating especially to the friends and family of the individual suffering from it. Hospitals and research centers are working their socks off to come up with a cancer cure.
The research for getting cancer treatment is overly expensive and mainly relies on donors to assist in the funding. Many donors are setting up cancer foundations to help research or offer care to cancer patients. Philanthropy has been vital in helping the cancer patients who cannot afford the expensive cancer treatment like chemotherapy.
Omar Boraie is a philanthropist who is all about humanity. He has been at the forefront of funding cancer research in educational institutions. It’s hard to come by people who are in charity work like Omar. Mr Boraie has been one of the major funders of groundbreaking cancer research being carried out by Rutgers Cancer Institute of New Jersey.
According to Patch.com, the Omar Boraie Chair in Genomic Science got recently established. These chairs represent the person commitment to an academic discipline by spurring it to the highest level. Mr Boraie, a New Brunswick developer, made a pledge of $1.5 as part of 18 chair challenge aimed at getting funding from donors.
The field of Genomic Science is working on transforming the medical professional’s approach to cancer diagnosis and treatment. Research is done to come up with the best analysis and treatment of cancer to get the best outcome when treating it. The government has been of full support to similar approach a sentiment that was taken up by President Obama during the launch of a national precision medicine initiative. The initiative is all about getting a cure for cancer and other diseases.
Several facilities have been researching on next-generation gene sequencing on cancer research. However, Rutgers Cancer Institute was one of the Pioneer centers to dwell into genomic sequencing. The study allows the physician to diagnose the cancer type precisely.
Genomic sequencing approach to cancer treatment has been very helpful for patients with rare cancer type, those who had a poor prognosis and those whose treatment options had been limited or ineffective.
The sky will be the limit for the organization with more funding from people like Omar Boraie. Contributing to a good cause is always a welcome especially helping people with terminal illness.